Skip to main content
Normal View

Thursday, 11 May 2023

Written Answers Nos. 270-280

Medicinal Products

Questions (270, 274)

Gino Kenny

Question:

270. Deputy Gino Kenny asked the Minister for Health if he is aware of the unavailability of medication for persons who suffer with diverticulosis, given that patients who are normally prescribed colofac and spasmonal cannot avail of this medication, and neither pharmacists nor GPs can confirm when these medications will be available from suppliers; the reason for the lack of supply of these medications; and if he will confirm when they will be available again. [22218/23]

View answer

Mark Ward

Question:

274. Deputy Mark Ward asked the Minister for Health if he is aware of a shortage of the medicines colofac and spasmonal within Ireland; the options available to those that are prescribed the medicines; the steps being taken to address the shortages; and if he will make a statement on the matter. [22281/23]

View answer

Written answers

I propose to take Questions Nos. 270 and 274 together.

The Department of Health is aware of the current shortage of Spasmonal 60 mg tablets, Spasmonal Forte 120 mg hard tables and Colofac 135 mg tablets in Ireland.

Mylan IRE Healthcare Limited, the company responsible for placing Colofac 135 mg tablets on the Irish market has notified a shortage of the product due to manufacturing delays. The company anticipates that resupply is expected during August 2023. Multiple countries are impacted. An alternative authorised product containing the same active substance (mebeverine) is available.

Mylan IRE Healthcare Limited, responsible for placing Spasmonal products on the Irish market, has also notified of a shortage due to active ingredient unavailability. It impacts multiple countries also. The company estimates that a resupply of Spasmonal Forte 120mg Hard Capsules is expected at the end of May 2023. The company is investigating the resupply date for Spasmonal 60mg Capsules.

Unfortunately, medicine shortages are a feature of modern health systems worldwide which have been exacerbated by recent worldwide events. There are a multitude of reasons why a medicine may not be available including: shortages of raw materials; manufacturing difficulties; sudden unexpected increase in demand; or product recalls due to potential quality issues. Ireland has a multi-stakeholder medicine shortage framework in place, coordinated by the HPRA. The Medicines Shortages Framework, operated by the HPRA on behalf of the Department of Health, aims to prevent, where possible, and mitigate the impact of medicines shortages. The framework allows for shortages to be carefully managed by the HPRA in close collaboration with the Department, the HSE, industry and healthcare professionals. The HPRA maintains regular contact with the Department of Health regarding medicines shortages.

The HPRA publishes a list of medicines currently in short supply on its website (Medicines Shortages (hpra.ie) with the reason for the shortage and expected dates for the return of supply. The information is available to assist healthcare professionals in managing medicine shortages when they arise and reduce their impact on patients. The information relating to shortages on the HPRA website is dynamic and changes depending on the current information the HPRA has to hand.

If a member of the public has any concerns regarding their treatment with these or any other medications, they should discuss this directly with their doctor or pharmacist.

Emergency Accommodation

Questions (271)

Holly Cairns

Question:

271. Deputy Holly Cairns asked the Minister for Health if he will clarify the legislative basis or policy rationale for the criteria that disused nursing homes, i.e., nursing homes registered with HIQA on or after 1 September 2022 will not be considered, are an approved accommodation category under the Offers of Commercial Accommodation for Beneficiaries of Temporary Protection from Ukraine; and if he will make a statement on the matter. [22224/23]

View answer

Written answers

The Department of Health takes the closures of nursing homes very seriously. The closure of nursing homes can put pressure on other local health and social care facilities. It is vital that the welfare of residents is ensured. There a number of reasons for nursing home closures each year including retirement, non-compliance with HIQA regulations, financial viability and, in some cases, recognition that the premises would not be compliant with revised regulations. Given the challenges currently being faced in the nursing home sector, Minister Donnelly and I agreed with the Minister for Children, Equality, Disability, Integration and Youth, Minister Roderic O'Gorman TD, to change the procurement guidelines around accommodation for persons under temporary protection in order to remove from consideration active nursing homes that were still registered operators with HIQA on or after the date of 1 September 2022. The intention behind this position is to avoid unintentionally incentivising active nursing homes to leave the market. Former nursing homes that had already ceased operation and were deregistered prior to this date would not be affected if they wished to enter into contracts as accommodation providers. This brings active nursing homes into the same category as other types of property that have been determined to be unsuitable as accommodation for Beneficiaries of Temporary Protection, including: • Housing set aside for social housing,• Accommodation planned for use by other arms of Government,• Student accommodation during academic terms The Department of Health has no direct role in the procurement process or the approval of any individual accommodation centres for use by displaced persons. The Department of Health and the Department of Children, Equality, Disability, Integration and Youth, under whose remit procurement and approval of accommodation centres for use by Beneficiaries of Temporary Protection falls, have indicated that they will continue to apply this position. Minister Donnelly and I, and the Department of Health, remain committed to continuing, constructive cross-Government engagement to address the health and social care needs of Beneficiaries of Temporary Protection as well as the identification of appropriate sites that might be used for accommodation. Given the changing situation with regard to accommodation for persons under temporary protection, the Department of Health is reviewing the policy agreed with the Department of Children, Equality, Disability, Integration and Youth with a view to providing longer-term certainty to the nursing home sector and potential providers of temporary accommodation services. The review is near completion.

Departmental Schemes

Questions (272)

Michael Healy-Rae

Question:

272. Deputy Michael Healy-Rae asked the Minister for Health if there are any plans to include the rare medical condition Gitelman's syndrome on the long-term illness scheme (details supplied); and if he will make a statement on the matter. [22235/23]

View answer

Written answers

The Long-Term Illness (LTI) Scheme was established under Section 59(3) of the Health Act 1970 (as amended). Regulations were made in 1971, 1973 and 1975, prescribing 16 illnesses covered by the Scheme. These are: acute leukaemia; mental handicap; cerebral palsy; mental illness (in a person under 16); cystic fibrosis; multiple sclerosis; diabetes insipidus; muscular dystrophies; diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide.

Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge.

While there are no current plans to extend the list of illnesses covered, my Department is currently examining all of the issues around the scope of the Scheme. It is also important to remember that the LTI Scheme exists within a wider eligibility framework.

This Government has put a significant focus on improving access to and the affordability of healthcare services, advancing substantial policy, legislation and investment to deliver expanded eligibility.

In 2022, a range of measures were delivered including the abolition of public inpatient charges for children, reductions in the Drug Payment Scheme threshold to €80 per month, and the introduction of free contraception for women aged 17-25.

The significant investment in Budget 2023 will facilitate better access to affordable, high-quality healthcare for people at a time when the cost-of-living crisis is impacting on everyone.

In 2023 this will mean:

• an expansion of GP care without charges to people earning no more than the median household income,

• all public in-patient hospital charges abolished since 17 April 2023,

• an extension of free contraception to 26-year-old women since 1 Jan 2023, and further extension to 27-30 years old women from 1 September 2023.

These measures continue to create a health and social care service that offers affordable access to quality healthcare.

In addition, people who cannot, without undue hardship, arrange for the provision of medical services for themselves and their dependants may be eligible for a medical card.

In accordance with the provisions of the Health Act 1970 (as amended), eligibility for a medical card is determined by the HSE. Medical card eligibility is primarily based on an assessment of means and is not granted on the basis of any particular condition.

In certain circumstances the HSE may exercise discretion and grant a medical card, even though an applicant exceeds the income guidelines, where he or she faces difficult financial circumstances, such as extra costs arising from illness. In circumstances where an applicant is still over the income limit for a medical card, they are then assessed for a GP visit card, which entitles the applicant to GP visits without charge.

Under the Drug Payment Scheme (DPS), no individual or family pays more than €80 a month towards the cost of approved prescribed medicines.

The DPS is not means tested and is available to anyone ordinarily resident in Ireland. The DPS significantly reduces the cost burden for families and individuals with ongoing expenditure on medicines.

Individuals may also be entitled to claim tax relief on the cost of their medical expenses, including medicines prescribed by a doctor, dentist, or consultant. Relief is at the standard tax rate of 20%.

Hospital Services

Questions (273)

Duncan Smith

Question:

273. Deputy Duncan Smith asked the Minister for Health the up-to-date position on 24/7 cardiac care in Waterford University Hospital; and if he will make a statement on the matter. [22244/23]

View answer

Written answers

As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Question No. 274 answered with Question No. 270.

Departmental Correspondence

Questions (275)

Mark Ward

Question:

275. Deputy Mark Ward asked the Minister for Health if he has received a petition from a group (details supplied); if he has replied to the group; and if he will make a statement on the matter. [22282/23]

View answer

Written answers

A petition has been received from this group via the Oireachtas Joint Committee on Public Petitions in recent days. A response in relation to this matter has not yet issued.

Local Drugs Task Forces

Questions (276, 277)

Thomas Gould

Question:

276. Deputy Thomas Gould asked the Minister for Health if his attention has been drawn to the fact that the Dún Laoghaire-Rathdown drug and alcohol task force is currently without a co-ordinator, despite the HSE having been informed by the task force as long ago as May 2022 that it had opted for a HSE-employed co-ordinator. [22283/23]

View answer

Thomas Gould

Question:

277. Deputy Thomas Gould asked the Minister for Health when the Dún Laoghaire-Rathdown drug and alcohol task force can expect to have in place a HSE-recruited co-ordinator; or, how and when the HSE intend to rectify this situation which is having a critical impact on the efficient running of vital services in the area; and if he will make a statement on the matter. [22284/23]

View answer

Written answers

I propose to take Questions Nos. 276 and 277 together.

As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Question No. 277 answered with Question No. 276.

Primary Care Centres

Questions (278)

Alan Dillon

Question:

278. Deputy Alan Dillon asked the Minister for Health if he will intervene as indicated in Dáil Éireann to resolve the impasse between the HSE, landlord and contractor(s) where construction work continues to be halted on a multi-million euro primary care centre in an area (details supplied); and if he will make a statement on the matter. [22292/23]

View answer

Written answers

I would like to thank the Deputy for again raising this important issue. As the Deputy is aware, the HSE has advised that the developer of the PCC in Ballyhaunis, Co. Mayo is having difficulty in agreeing completion works with subcontractors due to the increase in construction costs.

Officials in my Department continue to liaise with HSE Estates on the matter, and I have been assured that, while progress has been limited, the HSE is committed to engaging on an ongoing basis with the developer to assess options for moving forward with the completion of this centre. As you will appreciate, that HSE must operate within the bounds of the competitive process and lease agreement as it engages with the developer to address these issues.

I fully understand the frustration of the Deputy and the people of Ballyhaunis at the delays in completion of works at this centre. I wish to assure you that my Department will continue to engage with the HSE in relation to Ballyhaunis PCC in order to balance the priorities of achieving value for money and completing the delivery of a modern and high quality Primary Care Centre that the people of Ballyhaunis deserve.

Mental Health Services

Questions (279)

Mark Ward

Question:

279. Deputy Mark Ward asked the Minister for Health the pathways that are open to health professionals to train and specialise in child and youth mental health; if he will outline the list of courses in tabular form; if he will list the professions working within this area; if he will outline any future plans for these courses given the extension of CAMHS for up to 25-year-olds; and if he will make a statement on the matter. [22295/23]

View answer

Written answers

My Department is committed to ensuring that there is an adequate number of health and social care professionals to meet demand within the health service. 

As part of this commitment, Health officials engage on an ongoing basis with colleagues in the Department of Further and Higher Education, Research, Innovation and Science and other relevant stakeholders to ensure that we train enough graduates with the skills necessary to support the delivery of health and social care services and to develop a strategic approach to workforce planning for the health sector.

Recent data shows a consistent increase in students graduating as both undergraduate and postgraduate in medicine, pharmacy and nursing and midwifery between 2014 and 2020. Work is ongoing to add more educational places to expand the workforce to the largest extent possible.

Data from Health in Ireland Key Trends 2022 (DOH 2022) shows that students graduating as both undergraduate and postgraduate in medicine, pharmacy and nursing and midwifery increased consistently between 2014 and 2020, with the total number of students graduating increasing by 30% (from 4,841 to 6,264).

 Workforce planning for Mental Health Services is informed by “Sharing the Vision - A Mental Health Policy for Everyone” which outlines the vision for specialist mental health and community-based services.

 As the remainder part of this question is a service matter regarding specific training pathways, I am referring it to the HSE for direct reply.

Healthcare Policy

Questions (280)

Brendan Smith

Question:

280. Deputy Brendan Smith asked the Minister for Health further to Parliamentary Question No. 548 of 27 September 2022, the progress to date in reviewing the Tobacco Products Directive; and if he will make a statement on the matter. [22321/23]

View answer

Written answers

According to the Implementation Roadmap for Europe's Beating Cancer Plan, the EU Commission's Proposal for a revision of the Tobacco Products Directive will be adopted in 2024. The relevant Impact Assessment will also be published next year. My Department and the Health Service Executive will continue to engage with the Commission throughout this process, via surveys, consultations and participation in the Expert Group on Tobacco Policy.

Top
Share